Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_assertion type Assertion NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_head.
- NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_assertion description "[We also found that Ik6 variant and CRLF2 overexpression had an important role in dictating the prognosis of Ph-negative patients, which may be useful markers in guiding the treatment of ALL in the future, with tyrosine kinase inhibitors on the other hand reversing the fate of Ph-positive ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_provenance.
- NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_assertion evidence source_evidence_literature NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_provenance.
- NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_assertion SIO_000772 22297722 NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_provenance.
- NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_assertion wasDerivedFrom befree-20140225 NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_provenance.
- NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_assertion wasGeneratedBy ECO_0000203 NP905182.RAnMkiQ-m9lD0vA8wtCaHLLxX3Oz0NqlTqF2LjZG4tSSU130_provenance.